XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flow from operating activities:    
Net income $ 73,973 $ 30,764
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 170,910 100,840
Stock-based compensation expense 40,402 31,435
Income tax benefit related to exercise of stock options (44,975) (11,141)
Amortization and write-offs of loan origination costs 7,994 5,473
Loss on extinguishment of debt   3,954
Loss on sale or disposition of property and equipment 159 339
Deferred income taxes (39,712) (27,030)
Provision for doubtful accounts 2,684 601
Changes in operating assets and liabilities, excluding effects from acquisitions:    
Accounts receivable (14,603) (5,234)
Prepaid expenses and other assets (2,595) (5,109)
Accounts payable 2,610 (1,755)
Accrued expenses (18,429) (28,437)
Income taxes prepaid and payable 44,840 (1,125)
Deferred revenue 13,758 26,992
Net cash provided by operating activities 237,016 120,567
Cash flow from investing activities:    
Additions to property and equipment (18,870) (9,462)
Proceeds from sale of property and equipment 69 56
Cash paid for business acquisitions, net of cash acquired (309,432) (2,614,785)
Additions to capitalized software (6,137) (3,370)
Purchase of long-term investment (1,000)  
Net changes in restricted cash 700  
Net cash used in investing activities (334,670) (2,627,561)
Cash flow from financing activities:    
Cash received from debt borrowings, net of original issue discount   3,068,075
Repayments of debt (268,550) (823,448)
Proceeds from exercise of stock options 34,767 10,618
Withholding taxes related to equity award net share settlement (7,051)  
Income tax benefit related to exercise of stock options 44,975 11,141
Proceeds from common stock issuance, net   717,802
Purchase of common stock for treasury (13)  
Payment of fees related to refinancing activities (503) (45,781)
Dividends paid on common stock (37,452) (33,216)
Net cash (used in) provided by financing activities (233,827) 2,905,191
Effect of exchange rate changes on cash and cash equivalents (878) (3,964)
Net (decrease) increase in cash and cash equivalents (332,359) 394,233
Cash and cash equivalents, beginning of period 434,159 109,577
Cash and cash equivalents, end of period $ 101,800 $ 503,810